ELI LILLY AND COMPANY Investment Income, Interest
ELI LILLY AND COMPANY (LLY) reported Investment Income, Interest of $65.00 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-10-30.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2025-10-30
- ELI LILLY AND COMPANY investment income, interest for the quarter ending 2025-09-30 was $65.00M, a 35.98% increase year-over-year.
- ELI LILLY AND COMPANY investment income, interest for the quarter ending 2025-06-30 was $40.00M, a 7.24% increase year-over-year.
- ELI LILLY AND COMPANY investment income, interest for the quarter ending 2025-03-31 was $48.30M, a 5.46% increase year-over-year.
- ELI LILLY AND COMPANY investment income, interest for the quarter ending 2024-12-31 was $44.30M, a 0.45% decline year-over-year.
- ELI LILLY AND COMPANY investment income, interest for fiscal 2024 was $175.20M, a 0.92% increase from fiscal 2023.
- ELI LILLY AND COMPANY investment income, interest for fiscal 2023 was $173.60M, a 176.43% increase from fiscal 2022.
- ELI LILLY AND COMPANY investment income, interest for fiscal 2022 was $62.80M, a 147.24% increase from fiscal 2021.
- ELI LILLY AND COMPANY investment income, interest for fiscal 2021 was $25.40M, a 23.03% decline from fiscal 2020.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2025-09-30 | $65.00M 10-Q · filed 2025-10-30 | $105.00M derived: sum of 2 quarters · filed 2025-10-30 | $153.30M 10-Q · filed 2025-10-30 | $197.60M derived: sum of 4 quarters · filed 2025-10-30 | |
| 2025-06-30 | $40.00M 10-Q · filed 2025-08-07 | $88.30M 10-Q · filed 2025-08-07 | $132.60M derived: sum of 3 quarters · filed 2025-08-07 | $180.40M derived: sum of 4 quarters · filed 2025-10-30 | |
| 2025-03-31 | $48.30M 10-Q · filed 2025-05-01 | $92.60M derived: sum of 2 quarters · filed 2025-05-01 | $140.40M derived: sum of 3 quarters · filed 2025-10-30 | $177.70M derived: sum of 4 quarters · filed 2025-10-30 | |
| 2024-12-31 | $44.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $92.10M derived: sum of 2 quarters · filed 2025-10-30 | $129.40M derived: sum of 3 quarters · filed 2025-10-30 | $175.20M 10-K · filed 2025-02-19 | |
| 2024-09-30 | $47.80M 10-Q · filed 2025-10-30 | $85.10M derived: sum of 2 quarters · filed 2025-10-30 | $130.90M 10-Q · filed 2025-10-30 | $175.40M derived: sum of 4 quarters · filed 2025-10-30 | |
| 2024-06-30 | $37.30M 10-Q · filed 2025-08-07 | $83.10M 10-Q · filed 2025-08-07 | $127.60M derived: sum of 3 quarters · filed 2025-08-07 | $176.50M derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $45.80M 10-Q · filed 2025-05-01 | $90.30M derived: sum of 2 quarters · filed 2025-05-01 | $139.20M derived: sum of 3 quarters · filed 2025-05-01 | $185.20M derived: sum of 4 quarters · filed 2025-05-01 | |
| 2023-12-31 | $44.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $93.40M derived: sum of 2 quarters · filed 2025-02-19 | $139.40M derived: sum of 3 quarters · filed 2025-02-19 | $173.60M 10-K · filed 2025-02-19 | |
| 2023-09-30 | $48.90M 10-Q · filed 2024-10-30 | $94.90M derived: sum of 2 quarters · filed 2024-10-30 | $129.10M 10-Q · filed 2024-10-30 | $154.60M derived: sum of 4 quarters · filed 2025-02-19 | |
| 2023-06-30 | $46.00M 10-Q · filed 2024-08-08 | $80.20M 10-Q · filed 2024-08-08 | $105.70M derived: sum of 3 quarters · filed 2025-02-19 | $125.80M derived: sum of 4 quarters · filed 2025-02-19 | |
| 2023-03-31 | $34.20M 10-Q · filed 2024-04-30 | $59.70M derived: sum of 2 quarters · filed 2025-02-19 | $79.80M derived: sum of 3 quarters · filed 2025-02-19 | $90.00M derived: sum of 4 quarters · filed 2025-02-19 | |
| 2022-12-31 | $25.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $45.60M derived: sum of 2 quarters · filed 2025-02-19 | $55.80M derived: sum of 3 quarters · filed 2025-02-19 | $62.80M 10-K · filed 2025-02-19 | |
| 2022-09-30 | $20.10M 10-Q · filed 2023-11-02 | $30.30M derived: sum of 2 quarters · filed 2023-11-02 | $37.30M 10-Q · filed 2023-11-02 | $44.70M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-06-30 | $10.20M 10-Q · filed 2023-08-08 | $17.20M 10-Q · filed 2023-08-08 | $24.60M derived: sum of 3 quarters · filed 2024-02-21 | $31.60M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-03-31 | $7.00M 10-Q · filed 2023-04-27 | $14.40M derived: sum of 2 quarters · filed 2024-02-21 | $21.40M derived: sum of 3 quarters · filed 2024-02-21 | $26.80M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2021-12-31 | $7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $14.40M derived: sum of 2 quarters · filed 2024-02-21 | $19.80M derived: sum of 3 quarters · filed 2024-02-21 | $25.40M 10-K · filed 2024-02-21 | |
| 2021-09-30 | $7.00M 10-Q · filed 2022-11-01 | $12.40M derived: sum of 2 quarters · filed 2022-11-01 | $18.00M 10-Q · filed 2022-11-01 | $23.70M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-06-30 | $5.40M 10-Q · filed 2022-08-04 | $10.90M 10-Q · filed 2022-08-04 | $16.70M derived: sum of 3 quarters · filed 2023-02-22 | $22.50M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-03-31 | $5.50M 10-Q · filed 2022-04-29 | $11.30M derived: sum of 2 quarters · filed 2023-02-22 | $17.10M derived: sum of 3 quarters · filed 2023-02-22 | $24.20M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2020-12-31 | $5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $11.60M derived: sum of 2 quarters · filed 2023-02-22 | $18.70M derived: sum of 3 quarters · filed 2023-02-22 | $33.00M 10-K · filed 2023-02-22 | |
| 2020-09-30 | $5.80M 10-Q · filed 2021-10-27 | $12.90M derived: sum of 2 quarters · filed 2021-10-27 | $27.20M 10-Q · filed 2021-10-27 | $40.40M derived: sum of 4 quarters · filed 2022-02-23 | |
| 2020-06-30 | $7.10M 10-Q · filed 2021-08-03 | $21.40M 10-Q · filed 2021-08-03 | $34.60M derived: sum of 3 quarters · filed 2022-02-23 | $51.90M derived: sum of 4 quarters · filed 2022-02-23 | |
| 2020-03-31 | $14.30M 10-Q · filed 2021-04-30 | $27.50M derived: sum of 2 quarters · filed 2022-02-23 | $44.80M derived: sum of 3 quarters · filed 2022-02-23 | $64.20M derived: sum of 4 quarters · filed 2022-02-23 | |
| 2019-12-31 | $13.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $30.50M derived: sum of 2 quarters · filed 2022-02-23 | $49.90M derived: sum of 3 quarters · filed 2022-02-23 | $80.40M 10-K · filed 2022-02-23 | |
| 2019-09-30 | $17.30M 10-Q · filed 2020-10-28 | $36.70M derived: sum of 2 quarters · filed 2020-10-28 | $67.20M 10-Q · filed 2020-10-28 | $107.80M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2019-06-30 | $19.40M 10-Q · filed 2020-07-31 | $50.00M 10-Q · filed 2020-07-31 | $90.50M derived: sum of 3 quarters · filed 2021-02-17 | $122.60M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2019-03-31 | $30.60M 10-Q · filed 2020-05-01 | $71.10M derived: sum of 2 quarters · filed 2021-02-17 | $103.20M derived: sum of 3 quarters · filed 2021-02-17 | $144.40M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2018-12-31 | $40.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $72.60M derived: sum of 2 quarters · filed 2021-02-17 | $113.80M derived: sum of 3 quarters · filed 2021-02-17 | $159.30M 10-K · filed 2021-02-17 | $161.30M 10-K · filed 2019-02-19 |
| 2018-09-30 | $32.10M 10-Q · filed 2019-10-25 | $73.30M derived: sum of 2 quarters · filed 2019-10-25 | $118.80M 10-Q · filed 2019-10-25 | $170.60M derived: sum of 4 quarters · filed 2020-02-19 | |
| 2018-06-30 | $41.20M 10-Q · filed 2019-08-02 | $86.70M 10-Q · filed 2019-08-02 | $138.50M derived: sum of 3 quarters · filed 2020-02-19 | $183.60M derived: sum of 4 quarters · filed 2020-02-19 | |
| 2018-03-31 | $45.50M 10-Q · filed 2019-05-02 | $97.30M derived: sum of 2 quarters · filed 2020-02-19 | $142.40M derived: sum of 3 quarters · filed 2020-02-19 | $179.30M derived: sum of 4 quarters · filed 2020-02-19 | |
| 2017-12-31 | $51.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $96.90M derived: sum of 2 quarters · filed 2020-02-19 | $133.80M derived: sum of 3 quarters · filed 2020-02-19 | $166.40M 10-K · filed 2020-02-19 | $167.30M 10-K · filed 2018-02-20 |
| 2017-09-30 | $45.10M 10-Q · filed 2018-11-06 | $82.00M derived: sum of 2 quarters · filed 2018-11-06 | $114.60M 10-Q · filed 2018-11-06 | $145.70M derived: sum of 4 quarters · filed 2019-10-24 | |
| 2017-06-30 | $36.90M 10-Q · filed 2018-07-25 | $69.50M 10-Q · filed 2018-07-25 | $100.60M derived: sum of 3 quarters · filed 2019-10-24 | $129.70M derived: sum of 4 quarters · filed 2019-10-24 | |
| 2017-03-31 | $32.60M 10-Q · filed 2018-04-27 | $63.70M derived: sum of 2 quarters · filed 2019-10-24 | $92.80M derived: sum of 3 quarters · filed 2019-10-24 | $116.30M derived: sum of 4 quarters · filed 2019-10-24 | |
| 2016-12-31 | $31.10M derived: 8-K 12 month − 10-Q 9 month · filed 2019-10-24 | $60.20M derived: sum of 2 quarters · filed 2019-10-24 | $83.70M derived: sum of 3 quarters · filed 2019-10-24 | $107.90M 8-K · filed 2019-10-24 | $108.70M 10-K · filed 2017-02-21 |
| 2016-09-30 | $29.10M 10-Q · filed 2017-10-27 | $52.60M derived: sum of 2 quarters · filed 2017-10-27 | $76.80M 10-Q · filed 2017-10-27 | $100.60M derived: sum of 4 quarters · filed 2018-02-20 | |
| 2016-06-30 | $23.50M 10-Q · filed 2017-07-28 | $47.70M 10-Q · filed 2017-07-28 | $71.50M derived: sum of 3 quarters · filed 2018-02-20 | $92.70M derived: sum of 4 quarters · filed 2018-02-20 | |
| 2016-03-31 | $24.20M 10-Q · filed 2017-05-01 | $48.00M derived: sum of 2 quarters · filed 2018-02-20 | $69.20M derived: sum of 3 quarters · filed 2018-02-20 | $89.80M derived: sum of 4 quarters · filed 2018-02-20 | |
| 2015-12-31 | $23.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $45.00M derived: sum of 2 quarters · filed 2018-02-20 | $65.60M derived: sum of 3 quarters · filed 2018-02-20 | $87.00M 10-K · filed 2018-02-20 | |
| 2015-09-30 | $21.20M 10-Q · filed 2016-10-28 | $41.80M derived: sum of 2 quarters · filed 2016-10-28 | $63.20M 10-Q · filed 2016-10-28 | $87.40M derived: sum of 4 quarters · filed 2017-02-21 | |
| 2015-06-30 | $20.60M 10-Q · filed 2016-07-28 | $42.00M 10-Q · filed 2016-07-28 | $66.20M derived: sum of 3 quarters · filed 2017-02-21 | $95.00M derived: sum of 4 quarters · filed 2017-02-21 | |
| 2015-03-31 | $21.40M 10-Q · filed 2016-04-29 | $45.60M derived: sum of 2 quarters · filed 2017-02-21 | $74.40M derived: sum of 3 quarters · filed 2017-02-21 | $108.00M derived: sum of 4 quarters · filed 2017-02-21 | |
| 2014-12-31 | $24.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $53.00M derived: sum of 2 quarters · filed 2017-02-21 | $86.60M derived: sum of 3 quarters · filed 2017-02-21 | $121.00M 10-K · filed 2017-02-21 | |
| 2014-09-30 | $28.80M 10-Q · filed 2015-10-30 | $62.40M derived: sum of 2 quarters · filed 2015-10-30 | $96.80M 10-Q · filed 2015-10-30 | $131.00M derived: sum of 4 quarters · filed 2016-02-19 | |
| 2014-06-30 | $33.60M 10-Q · filed 2015-07-30 | $68.00M 10-Q · filed 2015-07-30 | $102.20M derived: sum of 3 quarters · filed 2016-02-19 | $134.40M derived: sum of 4 quarters · filed 2016-02-19 | |
| 2014-03-31 | $34.40M 10-Q · filed 2015-04-30 | $68.60M derived: sum of 2 quarters · filed 2016-02-19 | $100.80M derived: sum of 3 quarters · filed 2016-02-19 | $130.50M derived: sum of 4 quarters · filed 2016-02-19 | |
| 2013-12-31 | $34.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $66.40M derived: sum of 2 quarters · filed 2016-02-19 | $96.10M derived: sum of 3 quarters · filed 2016-02-19 | $119.70M 10-K · filed 2016-02-19 | |
| 2013-09-30 | $32.20M 10-Q · filed 2014-10-29 | $61.90M derived: sum of 2 quarters · filed 2014-10-29 | $85.50M 10-Q · filed 2014-10-29 | $111.50M derived: sum of 4 quarters · filed 2015-02-19 | |
| 2013-06-30 | $29.70M 10-Q · filed 2014-07-28 | $53.30M 10-Q · filed 2014-07-28 | $79.30M derived: sum of 3 quarters · filed 2015-02-19 | $105.00M derived: sum of 4 quarters · filed 2015-02-19 | |
| 2013-03-31 | $23.60M 10-Q · filed 2014-04-28 | $49.60M derived: sum of 2 quarters · filed 2015-02-19 | $75.30M derived: sum of 3 quarters · filed 2015-02-19 | $102.50M derived: sum of 4 quarters · filed 2015-02-19 | |
| 2012-12-31 | $26.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $51.70M derived: sum of 2 quarters · filed 2015-02-19 | $78.90M derived: sum of 3 quarters · filed 2015-02-19 | $105.00M 10-K · filed 2015-02-19 | |
| 2012-09-30 | $25.70M 10-Q · filed 2013-10-30 | $52.90M derived: sum of 2 quarters · filed 2013-10-30 | $79.00M 10-Q · filed 2013-10-30 | $103.40M derived: sum of 4 quarters · filed 2014-02-19 | |
| 2012-06-30 | $27.20M 10-Q · filed 2013-07-26 | $53.30M 10-Q · filed 2013-07-26 | $77.70M derived: sum of 3 quarters · filed 2014-02-19 | $99.90M derived: sum of 4 quarters · filed 2014-02-19 | |
| 2012-03-31 | $26.10M 10-Q · filed 2013-04-26 | $50.50M derived: sum of 2 quarters · filed 2014-02-19 | $72.70M derived: sum of 3 quarters · filed 2014-02-19 | $90.50M derived: sum of 4 quarters · filed 2014-02-19 | |
| 2011-12-31 | $24.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-19 | $46.60M derived: sum of 2 quarters · filed 2014-02-19 | $64.40M derived: sum of 3 quarters · filed 2014-02-19 | $79.90M 10-K · filed 2014-02-19 | |
| 2011-09-30 | $22.20M 10-Q · filed 2012-10-26 | $40.00M derived: sum of 2 quarters · filed 2012-10-26 | $55.50M 10-Q · filed 2012-10-26 | $69.50M derived: sum of 4 quarters · filed 2013-02-21 | |
| 2011-06-30 | $17.80M 10-Q · filed 2012-07-27 | $33.30M 10-Q · filed 2012-07-27 | $47.30M derived: sum of 3 quarters · filed 2013-02-21 | $63.60M derived: sum of 4 quarters · filed 2013-02-21 | |
| 2011-03-31 | $15.50M 10-Q · filed 2012-04-30 | $29.50M derived: sum of 2 quarters · filed 2013-02-21 | $45.80M derived: sum of 3 quarters · filed 2013-02-21 | $56.80M derived: sum of 4 quarters · filed 2013-02-21 | |
| 2010-12-31 | $14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $30.30M derived: sum of 2 quarters · filed 2013-02-21 | $41.30M derived: sum of 3 quarters · filed 2013-02-21 | $51.90M 10-K · filed 2013-02-21 | -$51.90M 10-K · filed 2011-02-22 |
| 2010-09-30 | $16.30M 10-Q · filed 2011-10-28 | $27.30M derived: sum of 2 quarters · filed 2011-10-28 | $37.90M 10-Q · filed 2011-10-28 | $51.70M derived: sum of 4 quarters · filed 2012-02-24 | |
| 2010-06-30 | $11.00M 10-Q · filed 2011-07-29 | $21.60M 10-Q · filed 2011-07-29 | $35.40M derived: sum of 3 quarters · filed 2012-02-24 | $50.60M derived: sum of 4 quarters · filed 2012-02-24 | |
| 2010-03-31 | $10.60M 10-Q · filed 2011-04-29 | $24.40M derived: sum of 2 quarters · filed 2012-02-24 | $39.60M derived: sum of 3 quarters · filed 2012-02-24 | $58.40M derived: sum of 4 quarters · filed 2012-02-24 | |
| 2009-12-31 | $13.80M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24 | $29.00M derived: sum of 2 quarters · filed 2012-02-24 | $47.80M derived: sum of 3 quarters · filed 2012-02-24 | $75.20M 10-K · filed 2012-02-24 | -$75.20M 10-K · filed 2011-02-22 |
| 2009-09-30 | $15.20M 10-Q · filed 2010-10-29 | $34.00M derived: sum of 2 quarters · filed 2010-10-29 | $61.40M 10-Q · filed 2010-10-29 | ||
| 2009-06-30 | $18.80M 10-Q/A · filed 2010-08-02 | $46.20M 10-Q/A · filed 2010-08-02 | |||
| 2008-12-31 | -$210.70M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |